327 related articles for article (PubMed ID: 37375352)
1. Research Progress on Neuroprotective Effects of Isoquinoline Alkaloids.
Li J; Wu Y; Dong S; Yu Y; Wu Y; Xiang B; Li Q
Molecules; 2023 Jun; 28(12):. PubMed ID: 37375352
[TBL] [Abstract][Full Text] [Related]
2. Aporphines and Parkinson's Disease: Medical Tools for the Future.
Fazel Nabavi S; Uriarte E; Rastrelli L; Modak B; Sobarzo-Sánchez E
Curr Top Med Chem; 2016; 16(17):1906-9. PubMed ID: 26845550
[TBL] [Abstract][Full Text] [Related]
3. New trends in the practical use of isoquinoline alkaloids as potential drugs applicated in infectious and non-infectious diseases.
Tuzimski T; Petruczynik A
Biomed Pharmacother; 2023 Dec; 168():115704. PubMed ID: 37862968
[TBL] [Abstract][Full Text] [Related]
4. A Pharmacological Appraisal of Neuroprotective and Neurorestorative Flavonoids Against Neurodegenerative Diseases.
Zhao J; Zhu M; Kumar M; Ngo FY; Li Y; Lao L; Rong J
CNS Neurol Disord Drug Targets; 2019; 18(2):103-114. PubMed ID: 30394219
[TBL] [Abstract][Full Text] [Related]
5. New therapeutic strategy for Parkinson's and Alzheimer's disease.
Esposito E; Cuzzocrea S
Curr Med Chem; 2010; 17(25):2764-74. PubMed ID: 20586718
[TBL] [Abstract][Full Text] [Related]
6. [Progress of antibacterial activity and antibacterial mechanism of isoquinoline alkaloids].
Cao P; Zhang ZW; Leng DJ; Li XY; Li Y
Zhongguo Zhong Yao Za Zhi; 2016 Jul; 41(14):2600-2606. PubMed ID: 28905593
[TBL] [Abstract][Full Text] [Related]
7. Current Drugs and Potential Future Neuroprotective Compounds for Parkinson's Disease.
Carrera I; Cacabelos R
Curr Neuropharmacol; 2019; 17(3):295-306. PubMed ID: 30479218
[TBL] [Abstract][Full Text] [Related]
8. Naringenin: A prospective therapeutic agent for Alzheimer's and Parkinson's disease.
Goyal A; Verma A; Dubey N; Raghav J; Agrawal A
J Food Biochem; 2022 Dec; 46(12):e14415. PubMed ID: 36106706
[TBL] [Abstract][Full Text] [Related]
9. Tanshinone IIA: A phytochemical as a promising drug candidate for neurodegenerative diseases.
Subedi L; Gaire BP
Pharmacol Res; 2021 Jul; 169():105661. PubMed ID: 33971269
[TBL] [Abstract][Full Text] [Related]
10. Clinical utility of neuroprotective agents in neurodegenerative diseases: current status of drug development for Alzheimer's, Parkinson's and Huntington's diseases, and amyotrophic lateral sclerosis.
Dunkel P; Chai CL; Sperlágh B; Huleatt PB; Mátyus P
Expert Opin Investig Drugs; 2012 Sep; 21(9):1267-308. PubMed ID: 22741814
[TBL] [Abstract][Full Text] [Related]
11. Biologically active isoquinoline alkaloids covering 2014-2018.
Shang XF; Yang CJ; Morris-Natschke SL; Li JC; Yin XD; Liu YQ; Guo X; Peng JW; Goto M; Zhang JY; Lee KH
Med Res Rev; 2020 Nov; 40(6):2212-2289. PubMed ID: 32729169
[TBL] [Abstract][Full Text] [Related]
12. Psychopharmacological neuroprotection in neurodegenerative disease: assessing the preclinical data.
Lauterbach EC; Victoroff J; Coburn KL; Shillcutt SD; Doonan SM; Mendez MF
J Neuropsychiatry Clin Neurosci; 2010; 22(1):8-18. PubMed ID: 20160205
[TBL] [Abstract][Full Text] [Related]
13. Neurodegenerative Diseases and Flavonoids: Special Reference to Kaempferol.
Rahul ; Siddique YH
CNS Neurol Disord Drug Targets; 2021; 20(4):327-342. PubMed ID: 33511932
[TBL] [Abstract][Full Text] [Related]
14. Natural isoquinoline alkaloids: Pharmacological features and multi-target potential for complex diseases.
Plazas E; Avila M MC; Muñoz DR; Cuca S LE
Pharmacol Res; 2022 Mar; 177():106126. PubMed ID: 35151857
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effects of nonsteroidal anti-inflammatory drugs on neurodegenerative diseases.
Asanuma M; Miyazaki I; Ogawa N
Curr Pharm Des; 2004; 10(6):695-700. PubMed ID: 14965332
[TBL] [Abstract][Full Text] [Related]
16. Plant isoquinoline alkaloids as potential neurodrugs: A comparative study of the effects of benzo[c]phenanthridine and berberine-based compounds on β-amyloid aggregation.
Marasco D; Vicidomini C; Krupa P; Cioffi F; Huy PDQ; Li MS; Florio D; Broersen K; De Pandis MF; Roviello GN
Chem Biol Interact; 2021 Jan; 334():109300. PubMed ID: 33098838
[TBL] [Abstract][Full Text] [Related]
17. Monoamine oxidase inhibitors as neuroprotective agents in age-dependent neurodegenerative disorders.
Naoi M; Maruyama W
Curr Pharm Des; 2010; 16(25):2799-817. PubMed ID: 20698822
[TBL] [Abstract][Full Text] [Related]
18. Icariin: A Potential Neuroprotective Agent in Alzheimer's Disease and Parkinson's Disease.
Khezri MR; Ghasemnejad-Berenji M
Neurochem Res; 2022 Oct; 47(10):2954-2962. PubMed ID: 35802286
[TBL] [Abstract][Full Text] [Related]
19. Silymarin and neurodegenerative diseases: Therapeutic potential and basic molecular mechanisms.
Haddadi R; Shahidi Z; Eyvari-Brooshghalan S
Phytomedicine; 2020 Dec; 79():153320. PubMed ID: 32920285
[TBL] [Abstract][Full Text] [Related]
20. Natural Products for the Treatment of Neurodegenerative Diseases.
Wang Z; He C; Shi JS
Curr Med Chem; 2020; 27(34):5790-5828. PubMed ID: 31131744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
